• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment


76.550 EUR 0.600 0.78%

As of 09:04:13 ET on 04/17/2014.

Snapshot for BioMerieux (BIM)

Open: 77.005 Day's Range: 76.375 - 77.530 Volume: 0
Previous Close: 77.150 52wk Range: 68.715 - 82.875 1-Yr Rtn: +6.74%

Stock Chart for BIM

No chart data available.
  • BIM:LI 76.445
  • 1D
  • 1M
  • 1Y
Interactive BIM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.4624
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 3.7410
Est. PEG Ratio 2.4073
Market Cap (M EUR) 3,020.18
Shares Outstanding (M) 39.45
30 Day Average Volume 61
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.31%
Cash Dividend (EUR) 1.0000
Dividend Ex-Date 06/03/2014
5 Year Dividend Growth -
Next Earnings Announcement 09/03/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIM

bioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. bioMerieux is also active in the analysis of food, pharmaceuticals, and environmental samples to determine their microbiological quality.

Jean-Luc BelingardChairmanAlexandre MerieuxChief Executive Officer
Henri ThomassonChief Financial OfficerMark MillerChief Medical Officer
More Company Profile & Key Executives for BIM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

  • BIM News

  • Industry News

Sponsored Links
sec ||= nil